The founders of Kumovis GmbH have set themselves the goal of enabling the additive production of plastic implants and are developing innovative 3D printers specifically for medical products. Kumovis focuses on the processing of high-performance polymers, which are already established in medical technology. With the Kumovis system these plastics can be processed individually, decentrally and with a high degree of design freedom. Through the integration of a unique air circuit including filter units, the technology enables a clean room environment within the build chamber. The contamination of the component with foreign particles can be avoided. As a result, the Kumovis printer can produce products such as implants cost-effectively and at the same time patient-individualized.

Press releases

HTGF Series A financing KUMOVIS

Press release Kumovis
Kumovis closes Series A funding led by Renolit and Solvay 3D printing system developer to enter new markets, accelerate growth, and enable medical device manufacturers to leverage the full potential of high-performance polymers Kumovis, the developer of the world’s…

High-Tech Gründerfonds invests in medical engineering of the future

Kumovis develops 3D printers specifically for medical technology. With its technology the team of Kumovis enables the manufacturing of individualized medical products, like patient-customized implants. The HTGF now participates in the seed financing round. This investment especially supports Kumovis‘ market launch…

Info & Contact

Miriam Haerst
+49 (0) 89 289 16711


Kumovis GmbH
Trimburgstr. 2
81249 München

In portfolio

22. Aug 2018